Navigation Links
Schering-Plough CEO to Buy $2 Million in Common Shares
Date:1/18/2008

KENILWORTH, N.J., Jan. 18 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced this morning that Chairman and CEO Fred Hassan intends to make an open market purchase of $2 million of Schering-Plough Common Shares with personal funds.

"As was the case in November 2003 when I purchased $4.68 million in Schering-Plough Common Shares at an average price of $15.42 (2003 press release below), this investment in Schering-Plough reflects my long-term confidence in the company, its products (including ZETIA and VYTORIN), and our late-stage pipeline," said Hassan. "The media interpretations of the top-line ENHANCE trial results, and the resulting stock price reaction, have been deeply troubling. I firmly believe in VYTORIN and ZETIA. Further, I believe this company is now a strong and diverse global competitor, with sound long- term fundamentals, that is capable of driving long-term growth. Our mission is 'To earn trust, every day,' and this personal stock purchase reflects my faith that, together, our 50,000 dedicated Schering-Plough employees can accomplish that mission."

Hassan had wanted to purchase the stock yesterday, when the stock closed at $21.62. However, it was determined that, under the federal securities laws, it would be better to defer the purchase until earnings for the fourth quarter and the full year 2007 are announced, scheduled for Feb. 12, 2008, and the full results of the ENHANCE trial are discussed in a scientific forum, anticipated for the American College of Cardiology meeting in late March. Hassan committed that the purchase will then be completed, whatever the stock price at that time. "I had already made a significant personal investment in Schering-Plough in 2003, and I believe that adding another $2 million to this personal investment is the right thing to do."

BELOW: 2003 PRESS RELEASE ON CEO STOCK PURCHASE

SCHERING-PLOUGH CEO BUYS $4.68 MILLION OF COMPANY COMMON STOCK

KENILWORTH, N
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
6. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
7. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
8. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
9. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
10. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
11. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...nables Personal Health Record Devices with Medical... PA (PRWEB) December 2, 2009 -- Perhaps the best m...wn medical records. With the advent of Person Heal...cal records is easier than ever. MyEMRChoice.com, ...company has added services that will populate exis...
(Date:12/2/2009)...ieves IBM Ready for LINUX designation and enhances...inframe and contemporary systems running Linux. ,...ber 2, 2009 -- eCube Systems, a leader in legacy e...unced that it has achieved the IBM Ready for LINUX...eware. This mark certifies NXTera has met compati...
(Date:12/2/2009)...FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPR...Health Care Conference today at 2:30 p.m. Eastern ...live and may be accessed through a link on the inv...probe.com . The webcast will be available for 30 d...,, Gen-Probe Incorporated is a global leader in...
(Date:12/2/2009)...ewswire/ -- Targeted breast ultrasound of suspicio..., reliable and cost-effective alternative to invas...the findings of two studies presented today at the...th America (RSNA). ,, "By performing high-quali...expensive and avoidable invasive diagnostic proced...
(Date:12/2/2009)...spicious areas of the breast, including lumps, is ... invasive biopsies for women under age 40, accordi...at the annual meeting of the Radiological Society ...uality breast ultrasound, we can reduce the number...ocedures in young women," said senior author Const...
Breaking Medicine News(10 mins):Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2
...affect younger men with clogged arteries leading t...to a research published in the current issue of Ps...// situation do not show any such tendencies, said...ply blood to the head, in men who reported having ...
...eading cause of accidental death for elderly peopl...as revealed that diabetics are four times more lik...rrently 150 million people are estimated to have t...g frail elderly nursing home residents, which incl...
...s for ears, which are done in a minimally invasive...he traditional way. Researchers from University of...earch finding // at the 109th Annual Meeting & OTO...mastoidectomy (a surgical removal of the mastoid a...
...ople on antiretroviral therapy has doubled to 1 mi...ia and Africa are two regions which are hit greatl...antiretroviral // treatment, it is still far less ...f those in Africa and 14% of those in Asia have ac...
...by physiological levels free radicals and antioxid...ve been well established following our improved un...rs // potential scope because of the fact that con...tation of antioxidants. Green tea consists of...
...r the threat posed by new virus-induced diseases l...ed institute has launched a course offering specia... // Biotechnology and Bioinformatics of the Univer...ended to provide qualified virologists to various ...
Other Medicine News:Health News:Protection against Alzheimer’s could be as simple as drinking green te 2Health News:Launch Of India’s First Virology Course At Pun 2
(Date:12/1/2009).... 1 The new position of Executive ...otechnologies, Inc. has been taken up by Howard Go... than 30 years of experience creating and managing... will direct Microchip Biotechnologies, marketing,...operations as the company makes the transition fro...
(Date:12/1/2009)...Dec. 1 Galenea Corp. and Otsuka Ph... extension of their research and development colla...eases the collaboration term to seven years and br...$90 million. The companies have been working toge...ng and developing first-in-class therapies for sch...
(Date:12/1/2009)...swire-FirstCall/ -- Neogen Corporation (Nasdaq: N...Kits food safety business of San Diego, Calif.-bas... includes more than 50 test kits for food allergen..., Gen-Probe acquired the BioKits business throu...April 2009. Gen-Probe elected to divest the food s...
Breaking Medicine Technology:Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3Neogen Acquires Gen-Probe's BioKits Food Safety Business 2AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 1AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 2AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 3AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 4AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 5AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 6AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 7VIVUS to Present at Lazard Capital Markets Healthcare Conference 6154 1VIVUS to Present at Lazard Capital Markets Healthcare Conference 6154 2Frost 26amp 3B Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market the Golden Standard in Patient Safety 61121 1Frost 26amp 3B Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market the Golden Standard in Patient Safety 61121 2Frost 26amp 3B Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market the Golden Standard in Patient Safety 61121 3
...ON, Oct. 16 The following is being,issued by Trus...ference call to discuss a new report from the,Amer...rica,s Health (TFAH),"Pandemic Influenza: Warning,...U.S. preparedness in treating and caring for child...ovides recommendations from AAP and TFAH for,how t...
....D. a noted Plastic,and Reconstructive Surgeon, is...l trial performing a minimally invasive breast rec... expansion system and liposuctioned,micro-fat graf...,lumpectomy, with or without radiation therapy. T... major, "open",surgery that requires extensive rec...
Other Medicine Technology:New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: